Evaluation of Balance and Functionality in Postmenopausal Osteoporosis Using Quadriceps Femoris Muscle Thickness, Beyond Thoracic Hyperkyphosis
NCT ID: NCT06760598
Last Updated: 2025-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
103 participants
OBSERVATIONAL
2022-07-01
2023-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How Vertebral Fractures Effect Balance In Postmenopausal Women
NCT06502301
Sarcopenia And Balance In Postmenopausal Osteoporosis
NCT03832088
Balance and Muscle Strength as Indicators of Fracture Risk in Postmenopausal Women
NCT06645600
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60
NCT07045012
Anthropometric And Body Composition Measurements Related To Osteoporosis In Geriatric Population
NCT04255173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Age, height, weight, body mass index (BMI), comorbidities, medications, previous surgeries, steroid use, previous fractures and the energy level of these fractures (low or high), fracture location, family history of fractures, alcohol use, smoking, menopausal age and the number of falls in a year were questioned. The FRAX algorithm was used to determine the risk of fracture.
The Cobb angle of thoracic kyphosis was calculated radiographically and QFM thickness was measured from anterior thigh via ultrasonography (USG). The presence of sarcopenia was determined. Balance, fall risk and physical function were evaluated with tandem stance and gait test, Berg balance scale (BBS), Timed up and go test (TUG), hand grip strength, chair stand test (CST).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who were able to ambulate without any assistive devices
Exclusion Criteria
* Visual and vestibular disease
* Previous major lower extremity surgery or previous vertebra surgery
* Advanced heart, liver, or renal failure
* Stage 4 knee osteoarthritis
* Psychiatric disorders
* Use of any medication affecting the central nervous system.
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eslem Peker Belene
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ESLEM PEKER BELENE
Role: PRINCIPAL_INVESTIGATOR
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
ZEYNEP ÜLKÜ AKARIRMAK
Role: STUDY_DIRECTOR
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
RANA TERLEMEZ
Role: STUDY_CHAIR
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
OSMAN AYKAN KARGIN
Role: STUDY_CHAIR
Istanbul University- Cerrahpasa, Cerrahpasa Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University Cerrahpasa
Istanbul, Istanbul, Turkey (Türkiye)
Istanbul University Cerrahpasa, Cerrahpasa Medical Faculty
Istanbul, SÜLEYMANPAŞA, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-83045809-604.01.01-439462
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.